A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The breakpoints of Df(2R)BSC858 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements PBac{WH}f04130 and P{XP}d01208 are 2R:10516812 ;10769027 and the cytological breakpoints predicted from these coordinates are 51B6;51D1.